Co-localisation of hypoxia and perfusion markers with parameters of glucose metabolism in human squamous cell carcinoma (hSCC) xenografts.

Co-localisation of hypoxia and perfusion markers with parameters of glucose metabolism in human squamous cell carcinoma (hSCC) xenografts.

Item
http://www.wikidata.org/entity/Q33515391
Potential of Induced Metabolic Bioluminescence Imaging to Uncover Metabolic Effects of Antiangiogenic Therapy in TumorsHypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symportersA pilot study on potential plasma hypoxia markers in the radiotherapy of non-small cell lung cancer. Osteopontin, carbonic anhydrase IX and vascular endothelial growth factor.Metabolic targeting of HIF-dependent glycolysis reduces lactate, increases oxygen consumption and enhances response to high-dose single-fraction radiotherapy in hypoxic solid tumors.Tp53-induced glycolysis and apoptosis regulator (TIGAR) protects glioma cells from starvation-induced cell death by up-regulating respiration and improving cellular redox homeostasisBAY 87-2243, a novel inhibitor of hypoxia-induced gene activation, improves local tumor control after fractionated irradiation in a schedule-dependent manner in head and neck human xenograftsPredicting outcomes in radiation oncology--multifactorial decision support systemsThe Sulfamate Small Molecule CAIX Inhibitor S4 Modulates Doxorubicin Efficacy.Identification of Metastasis-Associated Metabolic Profiles of Tumors by (1)H-HR-MAS-MRSThe Microenvironment of Cervical Carcinoma Xenografts: Associations with Lymph Node Metastasis and Its Assessment by DCE-MRI.Efficient (18)F-labeling of large 37-amino-acid pHLIP peptide analogues and their biological evaluation.Effects of three modifiers of glycolysis on ATP, lactate, hypoxia, and growth in human tumor cell lines in vivo.Feasibility of induced metabolic bioluminescence imaging in advanced ovarian cancer patients: first results of a pilot study.Measurement of the acute metabolic response to hypoxia in rat tumours in vivo using magnetic resonance spectroscopy and hyperpolarised pyruvate.Elucidating immunometabolic targets in glioblastoma.ACRIN 6684: Multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy.
P2860

Co-localisation of hypoxia and perfusion markers with parameters of glucose metabolism in human squamous cell carcinoma (hSCC) xenografts.

Item
http://www.wikidata.org/entity/Q33515391
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Co-localisation of hypoxia and ...... l carcinoma (hSCC) xenografts.
@ast
Co-localisation of hypoxia and ...... l carcinoma (hSCC) xenografts.
@en
Co-localisation of hypoxia and ...... human squamous cell carcinoma
@nl
type
label
Co-localisation of hypoxia and ...... l carcinoma (hSCC) xenografts.
@ast
Co-localisation of hypoxia and ...... l carcinoma (hSCC) xenografts.
@en
Co-localisation of hypoxia and ...... human squamous cell carcinoma
@nl
prefLabel
Co-localisation of hypoxia and ...... l carcinoma (hSCC) xenografts.
@ast
Co-localisation of hypoxia and ...... l carcinoma (hSCC) xenografts.
@en
Co-localisation of hypoxia and ...... human squamous cell carcinoma
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Co-localisation of hypoxia and ...... ll carcinoma (hSCC) xenografts
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921